Shares of Johnson Matthey (OTCMKTS:JMPLY) have been given a consensus recommendation of “Hold” by the six analysts that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and three have issued a buy recommendation on the company.

Several analysts have commented on the company. Zacks Investment Research downgraded Johnson Matthey from a “hold” rating to a “sell” rating in a research note on Saturday. Investec downgraded Johnson Matthey from a “hold” rating to a “sell” rating in a research note on Friday, April 12th.

Johnson Matthey stock opened at $80.75 on Friday. Johnson Matthey has a twelve month low of $67.00 and a twelve month high of $102.55.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

See Also: What is the downside to momentum investing?

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.